Literature DB >> 32454667

Design and Development of Crystallo-co-agglomerates of Ritonavir for the Improvement of Physicochemical Properties.

Nilesh M Mahajan1, Ashwini D Malghade1, Nitin G Dumore1, Raju R Thenge2.   

Abstract

OBJECTIVES: The aim of the present study was to obtain CCA of ritonavir to improve the solubility, dissolution rate, and other physicochemical properties.
MATERIALS AND METHODS: Ritonavir agglomerates were prepared using the CCA technique. Acetone-water containing HPMC K-15, PEG-6000, PVP K-30 was used as the crystallization medium. The agglomerates were evaluated for saturation solubility, micromeritic properties, yield, and drug content. The agglomerates were also characterized using FTIR, DSC, XRPD and SEM.
RESULTS: The growth of particle size and the spherical form of the agglomerates resulted in the formation of products with good flow and packing properties. The improved compaction properties of the agglomerated crystals were due to the fragmentation that occurred during compression. DSC and XRD studies showed that ritonavir particles crystallized in the presence of HPMC, PEG-6000, PVP K-30 and diluents did not undergo structural modifications. The solubility and dissolution rate of ritonavir agglomerates were improve compare to pure ritonavir.
CONCLUSION: CCA was successfully applied to improve the physicochemical properties of ritonavir. ©Copyright 2018 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  Crystallo-co-agglomeration; dissolution; ritonavir; solubility

Year:  2018        PMID: 32454667      PMCID: PMC7227833          DOI: 10.4274/tjps.44227

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  2 in total

Review 1.  Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Authors:  N Blagden; M de Matas; P T Gavan; P York
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

2.  Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration.

Authors:  Kevin Garala; Jaydeep Patel; Anjali Patel; Mihir Raval; Abhay Dharamsi
Journal:  Int J Pharm Investig       Date:  2012-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.